Phase 1 Study of CART-ddBCMA, a CAR-T therapy utilizing a novel synthetic binding domain, for the treatment of subjects with relapsed and refractory multiple myeloma.
Year: 2021
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Matthew J. Frigault, Elizabeth O'Donnell, Noopur S. Raje, Daniella Cook, Andrew Yee, Jacalyn Rosenblatt, Chelsey Gibson, Emma Logan, David Avigan, Michael Russell Bishop, Katherine Eckert, Heather Daley, Diego Hernandez Rodriguez, Andrew Mason, Sarah Nikiforow, Carissa Mangus, Aleksandra Gil-Krzewska, Scott Currence, Angela Shen, Marcela Valderrama Maus
Language: English
Topic: CAR-T cell therapy research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W3171103390